Canary Advisors®

Canary Advisors is a Durham, North Carolina-based patient advocacy and clinical trial support services firm dedicated to aligning clinical development programs with patient needs.

We partner with biopharma, nonprofit, and regulatory stakeholders to understand disease impacts, unmet needs, and patient preferences. Our approach centers on providing tailored solutions, including early-stage patient advocacy, regulatory and legislative support, access and reimbursement planning, and patient experience data collection.

Founded in 2022 by Jenn McNary, Richie Kahn, and Jen Shumsky, Canary Advisors combines decades of experience in rare disease clinical development, patient advocacy, and regulatory affairs. We’re committed to translating research into actionable insights that truly benefit patients and their families. We’ve been recognized for our responsiveness, impact, and innovative strategies, consistently prioritizing the patient voice in drug and device development.

Our team provides a range of services, from clinical trial concierge to patient-focused drug development consultancy, ensuring that every project is strategically aligned with corporate objectives and patient needs.